BEIJING SL PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.23 CNY | -0.84% |
|
-3.97% | -19.23% |
| Sales 2023 * | 1.03B 142M | Sales 2024 * | 1.18B 164M | Capitalization | 8.46B 1.17B |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 8.22 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 7.14 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 757 |
| Yield 2023 * |
1.46% | Yield 2024 * |
1.82% | Free-Float | 57.71% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.84% | ||
| 1 week | -3.97% | ||
| Current month | -6.48% | ||
| 1 month | -13.46% | ||
| 3 months | -10.54% | ||
| 6 months | -47.71% | ||
| Current year | -19.23% |
1 week
8.08
8.48
1 month
8.089.49
Current year
7.0510.25
1 year
7.0516.09
3 years
7.0516.09
5 years
7.0518.86
10 years
7.0533.72
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 60 | 06-06-10 |
Li Ji
DFI | Director of Finance/CFO | 43 | 23-04-23 |
Shu Jie Liang
BRD | Director/Board Member | 58 | 06-04-10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 60 | 06-06-10 |
Shu Jie Liang
BRD | Director/Board Member | 58 | 06-04-10 |
Yu Lin Chen
BRD | Director/Board Member | 79 | 06-04-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | -1.55% | - | |
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 8.23 | -0.84% | 9,826,348 |
| 24-04-18 | 8.3 | -0.95% | 12,546,180 |
| 24-04-17 | 8.38 | +3.46% | 12,955,170 |
| 24-04-16 | 8.1 | -2.41% | 15,618,280 |
| 24-04-15 | 8.3 | -1.43% | 12,885,420 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.
Sector
Pharmaceuticals
Calendar
2024-04-23
- Q1 2024 Earnings Release
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8.23
CNY
Average target price
12
CNY
Spread / Average Target
+45.81%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.23% | 1.18B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- 002038 Stock
